Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
25 studies found for:    Cardiomyopathy | Open Studies | NIH, U.S. Fed
Show Display Options
Rank Status Study
1 Not yet recruiting Dilated cardiomYopathy iNtervention With Allogeneic MyocardIally-regenerative Cells (DYNAMIC)
Conditions: Dilated Cardiomyopathy (DCM);   Ischemic Cardiomyopathy;   Nonischemic Cardiomyopathy;   Heart Failure
Intervention: Biological: Allogeneic Cardiosphere-Derived Cells (CDCs)
2 Recruiting HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
Condition: Hypertrophic Cardiomyopathy
Intervention: Other: None - this is an observational study
3 Recruiting PercutaneOus StEm Cell Injection Delivery Effects On Neomyogenesis in Dilated CardioMyopathy (The POSEIDON-DCM Study)
Condition: Non-ischemic Dilated Cardiomyopathy
Interventions: Procedure: Transendocardial injection;   Biological: Autologous hMSCs;   Biological: Allogeneic hMSCs
4 Recruiting Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Conditions: Recurrent Adult Hodgkin Lymphoma;   Recurrent Adult T-cell Leukemia/Lymphoma;   Recurrent/Refractory Childhood Hodgkin Lymphoma;   Stage I Adult Hodgkin Lymphoma;   Stage I Adult T-cell Leukemia/Lymphoma;   Stage I Childhood Hodgkin Lymphoma;   Stage II Adult Hodgkin Lymphoma;   Stage II Adult T-cell Leukemia/Lymphoma;   Stage II Childhood Hodgkin Lymphoma;   Stage III Adult Hodgkin Lymphoma;   Stage III Adult T-cell Leukemia/Lymphoma;   Stage III Childhood Hodgkin Lymphoma;   Stage IV Adult Hodgkin Lymphoma;   Stage IV Adult T-cell Leukemia/Lymphoma;   Stage IV Childhood Hodgkin Lymphoma
Interventions: Other: Anthropometry;   Other: Serum Biomarkers;   Other: Diagnostic/symptom checklist;   Procedure: Echocardiogram;   Other: 6 minute walk test (6MWT);   Behavioral: Participant Questionnaires (ages >14 years only)
5 Not yet recruiting Efficacy and Safety of ICD Implantation in the Elderly
Conditions: Cardiomyopathy;   Coronary Artery Disease;   Congestive Heart Failure;   Myocardial Infarction
Interventions: Device: Implantable Cardioverter Defibrillator;   Other: Optimal standard of care
6 Recruiting Feasibility and Effectiveness of Micronutrients as Palliative Care Therapy in Patients With Congestive Heart Failure
Conditions: Congestive Heart Failure;   Ischemic Cardiomyopathy
Intervention: Drug: Micronutrients
7 Recruiting Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM
Condition: Hypertrophic Cardiomyopathy
Interventions: Drug: Valsartan;   Drug: Placebo
8 Recruiting Hypertrophic Regression With N-Acetylcysteine in HCM
Condition: Hypertrophic Cardiomyopathy
Intervention: Drug: N-acetylcysteine (NAC)
9 Recruiting Inflammation, Cardiac Sympathetic Innervation, and Arrhythmic Sudden Death
Conditions: Ischemic Cardiomyopathy;   Dilated Cardiomyopathy;   Inflammation;   Sudden Cardiac Death
Intervention:
10 Recruiting Study of the Effect of SNPs in p53 and p53 Response Elements on the Inflammatory Response to DNA Damage
Conditions: Inflammation;   Cancer;   Cardiomyopathy
Intervention:
11 Recruiting Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome
Conditions: Albinism;   Intestinal Disease;   Kidney Disease;   Myocardial Disease;   Pulmonary Fibrosis
Intervention:
12 Recruiting Collaborative Care to Alleviate Symptoms and Adjust to Illness in Chronic Heart Failure (CASA) Trial
Condition: Chronic Heart Failure
Intervention: Other: CASA Intervention
13 Recruiting Lipid Biomarkers for Diabetic Heart Disease
Conditions: Type II Diabetes Mellitus;   Diabetes Complications
Interventions: Drug: Fenofibrate;   Drug: Placebo for fenofibrate
14 Recruiting Targeted, Highly Sensitive, Non-Invasive Cardiac Transplant Rejection Monitoring
Conditions: Cardiovascular Disease;   Acute Rejection of Cardiac Transplant;   Cardiac Transplant Rejection;   Heart Transplant Failure and Rejection
Intervention:
15 Recruiting Safety Study of Pyridostigmine in Heart Failure
Condition: Heart Failure
Intervention: Drug: Pyridostigmine Bromide
16 Recruiting Blended Collaborative Care for Heart Failure and Co-Morbid Depression
Conditions: Heart Failure, Systolic;   Depression;   Cardiovascular Disease
Interventions: Behavioral: Collaborative Care for Heart Failure;   Behavioral: Collaborative Care for Depression
17 Unknown  Prevalence of Chagas Disease in Immigrant Patients With Conduction Abnormalities on Electrocardiogram
Condition: Chagas Disease
Intervention: Procedure: Trypanosoma cruzi serology
18 Recruiting Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Condition: Acute Heart Failure
Interventions: Drug: Liraglutide;   Drug: Placebo
19 Unknown  The Effect of Diet and Exercise in Heart Failure
Conditions: Heart Failure, Congestive;   Metabolic Syndrome X;   Obesity
Intervention: Behavioral: Lifestyle Modification (diet, exercise, and behavior)
20 Recruiting Palliative Care in Heart Failure
Conditions: Heart Failure;   Heart Diseases;   Cardiovascular Diseases
Intervention: Behavioral: Usual heart failure care + interdisciplinary palliative care

   Previous Page Studies Shown (1-20) Next Page (21-25) Show next page of results    Last Page
Indicates status has not been verified in more than two years